{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T04:24:10Z","timestamp":1741839850042,"version":"3.38.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.intimp.2011.09.016","type":"journal-article","created":{"date-parts":[[2011,10,17]],"date-time":"2011-10-17T17:35:28Z","timestamp":1318872928000},"page":"2181-2187","source":"Crossref","is-referenced-by-count":6,"title":["Chronic anti-phencyclidine monoclonal antibody therapy decreases phencyclidine-induced in utero fetal mortality in pregnant rats"],"prefix":"10.1016","volume":"11","author":[{"given":"J.J.","family":"Hubbard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Laurenzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.K.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.B.","family":"Gentry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2011.09.016_bb0005","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.intimp.2006.01.008","article-title":"Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats","volume":"6","author":"Gentry","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2011.09.016_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1517\/14656566.4.2.213","article-title":"Anti-cocaine vaccines: antibody protection against relapse","volume":"4","author":"Kantak","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.intimp.2011.09.016_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0091-3057(78)90295-2","article-title":"Effects of passive immunization against morphine on heroin self-administration","volume":"9","author":"Killian","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.intimp.2011.09.016_bb0020","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1124\/jpet.108.146407","article-title":"The effect of a chimeric human\/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats","volume":"328","author":"Norman","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1056\/NEJM198211253072201","article-title":"Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases","volume":"307","author":"Smith","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2011.09.016_bb0030","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-3565(25)20654-1","article-title":"Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats","volume":"278","author":"Valentine","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0195","series-title":"Principles of drug dependence treatment","first-page":"1","author":"WHO-UNODC","year":"2008"},{"key":"10.1016\/j.intimp.2011.09.016_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pharmthera.2005.06.009","article-title":"Immunotherapy for the treatment of drug abuse","volume":"108","author":"Kosten","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0045","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0090-9556(24)15342-1","article-title":"The effect of rate of drug administration on the extent and time course of phencyclidine distribution in rat brain, testis, and serum","volume":"28","author":"Proksch","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.intimp.2011.09.016_bb0050","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1124\/jpet.103.053140","article-title":"Treatment of adverse effects of excessive phencyclidine exposure in rats with a minimal dose of monoclonal antibody","volume":"306","author":"Laurenzana","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0055","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/jpet.105.097873","article-title":"Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats","volume":"317","author":"Pentel","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0060","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0022-3565(24)35360-1","article-title":"Anti-phencyclidine monoclonal antibodies provide long-term reductions in brain phencyclidine concentrations during chronic phencyclidine administration in rats","volume":"292","author":"Proksch","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0065","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrd984","article-title":"Therapeutic antibodies for human diseases at the dawn of the twenty-first century","volume":"2","author":"Brekke","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.intimp.2011.09.016_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1471-0528.2003.02158.x","article-title":"Pharmacokinetics of anti-D IgG in pregnant RhD-negative women","volume":"110","author":"Bichler","year":"2003","journal-title":"BJOG"},{"key":"10.1016\/j.intimp.2011.09.016_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.0958-7578.2004.0493.x","article-title":"Pharmacokinetics and safety of recombinant anti-RhD in healthy RhD-negative male volunteers","volume":"14","author":"Bichler","year":"2004","journal-title":"Transfus Med"},{"key":"10.1016\/j.intimp.2011.09.016_bb0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.intimp.2011.09.016_bb0085","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.intimp.2006.06.013","article-title":"Changes in maternal and fetal nicotine distribution after maternal administration of monoclonal nicotine-specific antibody to rats","volume":"6","author":"Keyler","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.intimp.2011.09.016_bb0090","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1124\/dmd.105.004234","article-title":"Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose\u2013 and affinity\u2013response relationships","volume":"33","author":"Keyler","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.intimp.2011.09.016_bb0095","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/jpet.102.046805","article-title":"Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats","volume":"305","author":"Keyler","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"year":"1997","author":"Zukin","series-title":"Substance abuse: a comprehensive textbook","key":"10.1016\/j.intimp.2011.09.016_bb0100"},{"key":"10.1016\/j.intimp.2011.09.016_bb0105","series-title":"Psychiatry","first-page":"1090","article-title":"Substance abuse: phencyclidine use disorders","author":"Javitt","year":"2008"},{"key":"10.1016\/j.intimp.2011.09.016_bb0110","first-page":"383","article-title":"Effects of gestational exposure to phencyclidine: distribution and neurochemical alterations in maternal and fetal brain","volume":"10","author":"Ali","year":"1989","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2011.09.016_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00003081-199306000-00009","article-title":"Cocaine, heroin, and phencyclidine: obstetric perspectives","volume":"36","author":"Glantz","year":"1993","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.intimp.2011.09.016_bb0120","first-page":"301","article-title":"Phencyclidine in pregnancy: a case report","volume":"27","author":"Petrucha","year":"1982","journal-title":"J Reprod Med"},{"key":"10.1016\/j.intimp.2011.09.016_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-0773.2002.900105.x","article-title":"Prenatal phencyclidine induces heightened neurodegeneration in rats in some brain regions, especially during 2nd trimester, but possible anti-apoptotic effects in others","volume":"90","author":"Jebelli","year":"2002","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.intimp.2011.09.016_bb0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/00952999009001595","article-title":"Perinatal outcome associated with PCP versus cocaine use","volume":"16","author":"Tabor","year":"1990","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.intimp.2011.09.016_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004311-200201000-00004","article-title":"Cardiovascular effects of intravenous anesthetics","volume":"40","author":"Patel","year":"2002","journal-title":"Int Anesthesiol Clin"},{"key":"10.1016\/j.intimp.2011.09.016_bb0140","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/S0196-0644(81)80118-7","article-title":"Acute phencyclidine intoxication: clinical patterns, complications, and treatment","volume":"10","author":"McCarron","year":"1981","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.intimp.2011.09.016_bb0145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1124\/dmd.105.005934","article-title":"Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted","volume":"34","author":"Pitas","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.intimp.2011.09.016_bb0150","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/jpet.110.175083","article-title":"The fate and function of therapeutic antiaddiction monoclonal antibodies across the reproductive cycle of rats","volume":"336","author":"Hubbard","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0155","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(24)37498-1","article-title":"Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs","volume":"285","author":"Hardin","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0160","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-0378(00)00053-X","article-title":"Murine fetal resorption and experimental pre-eclampsia are induced by both excessive Th1 and Th2 activation","volume":"47","author":"Hayakawa","year":"2000","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.intimp.2011.09.016_bb0165","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0300-483X(76)90033-0","article-title":"Oxonic acid and fetal development: II. Teratogenicity in rats","volume":"6","author":"Gralla","year":"1976","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2011.09.016_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/jpet.302.1.119","article-title":"A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats","volume":"302","author":"Hardin","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.intimp.2011.09.016_bb0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0022-3565(25)20389-5","article-title":"Phencyclidine dependence: the relationship of dose and serum concentrations to operant behavioral effects","volume":"258","author":"Wessinger","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.intimp.2011.09.016_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.283.5398.70","article-title":"Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain","volume":"283","author":"Ikonomidou","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.intimp.2011.09.016_bb0190","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1875-9572(10)60054-X","article-title":"Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair","volume":"51","author":"Su","year":"2010","journal-title":"Pediatr Neonatol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911003778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911003778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:57:44Z","timestamp":1741823864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576911003778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1567576911003778"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2011.09.016","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}